Brought to you by WBIW News and Network Indiana
Last updated on Friday, August 13, 2010
(INDIANAPOLIS, IN) - Indianapolis-based Eli Lilly and company has lost a legal battle over the patent for its ADHD drug Strattera.
A U.S. district court has ruled that Lilly's method-of-use patent is invalid, allowing for a generic version of the drug to enter the market in the near future.
Lilly Chairman and Chief Executive Officer John Lechleiter expects the loss of revenue to add to the challenges facing the company.
© Ad-Venture Media, Inc. All Rights Reserved.
Click here to go back to previous page